Original products based on recombinant DNA technology and molecular biology
Amgen, the world leader in biotechnology, has been harnessing the power of scientific innovation for 30 years to decisively improve patients’ lives.
Amgen is at the forefront of developing original products based on recombinant DNA technology and molecular biology, having launched biotechnology’s first breakthrough drugs. Today Amgen ranks in the Fortune 500, helps millions of patients fight serious diseases, and remains true to its science-based principles.
